九安医疗：糖尿病O+O模式中美落地进展顺利

Core Viewpoint - The company is actively advancing its "Internet + Healthcare" strategy, particularly focusing on the diabetes O+O model in both the US and China, with significant progress reported in patient management and revenue growth [1] Group 1: Business Development - The diabetes O+O model aims for full implementation in the US and China by the end of 2025, with ongoing expansion efforts [1] - As of the latest report, the model has been established in 50 cities across China and 394 hospitals, managing over 329,000 diabetes patients [1] - In the US, partnerships have been formed with approximately 74 clinics and 388 doctors, serving around 20,000 patients [1] Group 2: Performance Metrics - The management of diabetes patients has shown significant improvement, with the rate of achieving target HbA1c levels increasing from about 30% to 60% [1] - The adverse event rate has decreased to below 5%, and the standardized management rate has improved to 70% [1] - The company reported a revenue of 76.16 million yuan from diabetes care services in 2024 [1]